- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- 46 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 2 residues within 4Å:- Chain A: N.1046
- Chain C: Q.867
Ligand excluded by PLIPNAG.3: 2 residues within 4Å:- Chain A: Q.22, N.55
Ligand excluded by PLIPNAG.4: 3 residues within 4Å:- Chain A: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.99, E.121, F.147
Ligand excluded by PLIPNAG.6: 4 residues within 4Å:- Chain A: N.109, T.111, N.112, V.114
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: N.148
- Chain B: A.329
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain A: S.95, T.96, N.217
Ligand excluded by PLIPNAG.9: 4 residues within 4Å:- Chain A: D.257, E.258, N.259
- Chain B: R.534
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: N.308, K.556
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain A: N.320, S.348
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: N.347
- Chain B: Y.432, Y.465
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: N.592
- Chain C: M.806
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.681, G.1103
Ligand excluded by PLIPNAG.15: 5 residues within 4Å:- Chain A: N.689, F.690, Q.894, Q.898, Q.1043
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.1106
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: Q.867
- Chain B: A.678, N.1046
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain B: Q.22, N.55
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.99, E.121, F.147
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: N.109, S.110, N.112, I.154
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain B: F.147, N.148
- Chain C: A.329
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain B: T.96, N.217
- Chain C: K.437, R.439, E.442
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: E.258, N.259
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.308, K.556
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.320
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.347
- Chain C: Y.432, Y.465
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: M.806, Q.808
- Chain B: N.592, T.594
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.689, Q.898, Q.1043
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.1106
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.1046
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: Q.22, N.55
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain C: N.99, E.121, F.147
- Ligands: NAG.42
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain C: N.109, S.110, T.111, N.112, V.114, I.154
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain A: A.329, I.445
- Chain C: F.147, N.148
- Ligands: NAG.40
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain A: R.439
- Chain C: S.95, T.96, N.217, T.219
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain A: R.534
- Chain C: D.257, E.258, N.259
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.308, K.556
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain A: Y.432, Y.465
- Chain C: N.347
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: M.806
- Chain C: N.592
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.681
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: N.689, Q.894, Q.1043
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain C: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.1106
Ligand excluded by PLIP- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
BLA.18: 12 residues within 4Å:- Chain A: N.86, V.88, R.89, W.91, N.108, V.113, F.158, R.173, F.175, K.188, I.209, F.210
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:N.86, A:W.91, A:K.188, A:I.209, A:F.210
- Hydrogen bonds: A:N.108, A:K.188
- pi-Cation interactions: A:R.173
BLA.35: 10 residues within 4Å:- Chain B: V.88, R.89, W.91, N.108, V.113, F.158, R.173, F.175, K.188, I.209
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:R.89, B:W.91, B:F.175, B:K.188, B:I.209
- pi-Cation interactions: B:K.188
BLA.52: 10 residues within 4Å:- Chain C: N.86, V.88, R.89, W.91, N.108, V.113, R.173, F.175, K.188, I.209
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:N.86, C:W.91, C:K.188, C:I.209
- Hydrogen bonds: C:N.108
- pi-Cation interactions: C:K.188
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-11-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- 46 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-11-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C